ORAL 5-AZACYTIDINE AND ROMIDEPSIN EXHIBIT MARKED ACTIVITY IN PATIENTS WITH PTCL: A MULTICENTER PHASE I STUDY.

O'Connor, Owen A; Falchi, Lorenzo; Lue, Jennifer K; Marchi, Enrica; Kinahan, Cristina; Sawas, Ahmed; Deng, Changchun; Montanari, Francesca; Amengual, Jennifer Effie; Kim, Hye A; Rada, Aishling M; Khan, Karen; Jacob, Alice T; Malanga, Michelle; Francescone, Mark; Nandakumar, Renu; Soderquist, Craig; Park, David C; Bhagat, Govind; Cheng, Bin; Risueno, Alberto; Menezes, Daniel; Shustov, Andrei R; Sokol, Lubomir; Scotto, Luigi.
Blood; 2019 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-31471376